SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/5325139751F8A4872515BFEA392677D4A0FFF3C386DDD89D7A4012151A6C5DC9580067827EE544707134E6C24826BC15>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/5325139751F8A4872515BFEA392677D4A0FFF3C386DDD89D7A4012151A6C5DC9580067827EE544707134E6C24826BC15
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5325139751F8A4872515BFEA392677D4A0FFF3C386DDD89D7A4012151A6C5DC9580067827EE544707134E6C24826BC15
http://www.w3.org/2000/01/rdf-schema#comment
"Transfection of myoblasts with dominant-negative MEK5 blocked the pro-myogenic action of IGF-2."
xsd:string
http://purl.uniprot.org/uniprot/#_E4F48791B3BE5EE9BE7D87E70F74D8FBDFD220484ED69918D229428913D2AFC429D633FCD8CC72E324ACECC449671298
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/5325139751F8A4872515BFEA392677D4A0FFF3C386DDD89D7A4012151A6C5DC9580067827EE544707134E6C24826BC15
http://purl.uniprot.org/uniprot/Q9CXY7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5325139751F8A4872515BFEA392677D4A0FFF3C386DDD89D7A4012151A6C5DC9580067827EE544707134E6C24826BC15
http://purl.uniprot.org/uniprot/#_Q9CXY7-mappedCitation-19654213
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5325139751F8A4872515BFEA392677D4A0FFF3C386DDD89D7A4012151A6C5DC9580067827EE544707134E6C24826BC15